Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Penn study finds no increased cardiovascular risk if mildly underactive thyroid left untreated

01.03.2006


Researchers to question whether treatment is necessary for mild thyroid problems, based on study findings



Researchers at the University of Pennsylvania School of Medicine have found that leaving a mildly underactive thyroid gland (subclinical hypothyroidism) untreated does not lead to increased cardiovascular risk. The study results, to be published in the March 1st issue of the Journal of the American Medical Association, may lead to changes in the clinical treatment of this commonly diagnosed ailment.

The thyroid gland, located at the base of the neck, produces thyroid hormone, which acts throughout the body to regulate metabolism. Patients with underactivity of the thyroid gland, or hypothyroidism, may suffer from a variety of symptoms affecting the functions of the body. These patients are typically treated with medication to increase the thyroid hormone in the body. Likewise, patients with overactivity of the thyroid gland, or hyperthyroidism, may also be symptomatic and require treatment to lower their thyroid hormone levels.


In general, mild thyroid problems are common and often the symptoms can be subtle. It’s still unclear exactly who needs to be checked for it and what the risks and benefits of treatment are. Researchers aren’t sure whether treating a patient with a mild thyroid problem actually helps them.

"Previous studies have suggested that abnormal levels of thyroid stimulating hormone may represent a cardiac risk factor, the way that increased cholesterol or smoking are risk factors for heart disease." said lead author Anne Cappola, MD, ScM, Assistant Professor of Medicine and Epidemiology. "We set out to answer the question of whether there are cardiovascular consequences resulting from mild thyroid problems."

In this study, Cappola measured thyroid function through a blood test in 3200 men and women, aged 65 and older. These were people who had no reason to have an abnormal test and were not taking thyroid hormone replacement. She categorized them into different groups based on their thyroid blood tests and followed them for 13 years. Cappola found that 1.5% of the group who had a mildly overactive thyroid (subclinical hyperthyroidism) had an increased risk of developing an abnormal heart rhythm, atrial fibrillation, but no other cardiovascular threats such as heart attacks or death. Those with a mildly underactive thyroid gland made up 15 percent of the study, and showed no elevation in their risk of suffering a heart attack, stroke, or death.

Cappola adds, "It’s our wish to figure out what is a normal number versus an abnormal number… which thyroid level is associated with the highest level of function. Many patients with mild thyroid problems are being treated now and it’s not clear if it’s actually helping them. We need to put together a bigger picture for the risks and benefits of treatment for mild thyroid abnormalities."

So should general practitioners be screening patients over a certain age every so often for thyroid dysfunction? Some organizations recommend it. "We say there’s no evidence, based on our data, that screening would benefit the population. But if you do find someone over the age of 65 with a mildly overactive thyroid, they should be treated," explains Cappola. "There’s no evidence you should treat someone with a mildly underactive thyroid in order to help deter cardiovascular disease."

The results of this study will be published in the March 1st, 2006 issue of "JAMA." You can access the journal on-line at: http://jama.ama-assn.org/. The article is titled, "Thyroid Status, Cardiovascular Risk and Mortality, in Older Adults."

Susanne Hartman | EurekAlert!
Further information:
http://www.uphs.upenn.edu
http://jama.ama-assn.org/

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>